Navigation Links
Drugs found to both prevent and treat Alzheimer's disease in mice
Date:5/21/2013

Researchers at USC have found that a class of pharmaceuticals can both prevent and treat Alzheimer's Disease in mice.

The drugs, known as "TSPO ligands," are currently used for certain types of neuroimaging.

"We looked at the effects of TSPO ligand in young adult mice when pathology was at an early stage, and in aged mice when pathology was quite severe," said lead researcher Christian Pike of the USC Davis School of Gerontology. "TSPO ligand reduced measures of pathology and improved behavior at both ages."

The team's findings were published online by the Journal of Neuroscience on May 15. Pike's coauthors include USC postdoctoral scientists Anna M. Barron, Anusha Jayaraman and Joo-Won Lee; as well as Donatella Caruso and Roberto C. Melcangi of the University of Milan and Luis M. Garcia-Segura of the Instituto Cajal in Spain.

The most surprising finding for Pike and his team was the effect of TSPO ligand in the aged mice. Four treatmentsonce per week over four weeksin older mice resulted in a significant decrease of Alzheimer's-related symptoms and improvements in memory meaning that TSPO ligands may actually reverse some elements of Alzheimer's disease.

"Our data suggests the possibility of drugs that can prevent and treat Alzheimer's," Pike said. "It's just mouse data, but extremely encouraging mouse data. There is a strong possibility that TSPO ligands similar to the ones used in our study could be evaluated for therapeutic efficacy in Alzheimer's patients within the next few years."

Next, the team will next focus on understanding how TSPO ligands reduce Alzheimer's disease pathology. Building on the established knowledge that TSPO ligands can reduce inflammationshielding nerve cells from injury and increasing the production of neuroactive hormones in the brainthe team will study which of these actions is the most significant in fighting Alzheimer's disease so they can develop newer TSPO ligands accordingly.


'/>"/>

Contact: Robert Perkins
perkinsr@usc.edu
213-740-9226
University of Southern California
Source:Eurekalert

Related biology news :

1. Renaissance in new drugs for rare diseases
2. Renaissance in new drugs for rare diseases: Report in worlds largest scientific socity magazine
3. How do anticancer drugs work?
4. Mapping of cancer cell fuel pumps paves the way for new drugs
5. Co-Q10 deficiency may relate to concern with statin drugs, higher risk of diabetes
6. Cholesterol rafts deliver drugs inside cancer cells
7. Findings to help in design of drugs against virus causing childhood illnesses
8. KU Leuven lab coordinates €9m effort to find new deep-sea drugs
9. Mood-modifying drugs for humans also alter fish behavior
10. Study finds potential to match tumors with known cancer drugs
11. £6.5M in funding to help manufacture the drugs of the future
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/13/2017)... 13, 2017 UBM,s Advanced Design and Manufacturing ... feature emerging and evolving technology through its 3D Printing ... run alongside the expo portion of the event and ... demonstrations focused on trending topics within 3D printing and ... manufacturing event will take place June 13-15, 2017 at the ...
(Date:4/11/2017)... Research and Markets has announced the addition of the ... ... to grow at a CAGR of 30.37% during the period 2017-2021. ... been prepared based on an in-depth market analysis with inputs from ... prospects over the coming years. The report also includes a discussion ...
(Date:4/6/2017)... , April 6, 2017 Forecasts ... ANPR, Document Readers, by End-Use (Transportation & Logistics, Government ... Oil, Gas & Fossil Generation Facility, Nuclear Power), Industrial, ... Other) Are you looking for a definitive ... ...
Breaking Biology News(10 mins):
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... Cynvenio ... the launch of a new neoadjuvant breast cancer monitoring (NEAT) study in partnership with ... 10 centers and over 150 patients to be monitored over two years with Cynvenio’s ...
(Date:4/27/2017)... ... 27, 2017 , ... Proscia Inc., a ... technology has the potential to eliminate subjectivity in the detection and classification of ... part of the 2017 ISBI CAMELYON Digital Pathology Challenge, organized by ...
(Date:4/27/2017)... , ... April 27, 2017 , ... ... explaining why mass flow controllers based on capillary thermal mass flow technology provide ... mass flow control applications. Over 80% of all industrial processes—such as those ...
(Date:4/27/2017)... , April 27, 2017  Kinexum, a distinguished resource ... today announces the appointment of Thomas C. Seoh ... ("Zan") Fleming, M.D., Kinexum founder, who becomes Executive Chairman ... to Kinexum clients. Thomas Seoh ... the Kinexum mission and lead the firm,s remarkable team ...
Breaking Biology Technology: